The current consensus among 1 polled investment analysts is to Hold stock in PharmaCyte Biotech Inc. This rating has held steady since July, when it was unchanged from a Hold rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.07
Reporting Date Aug 22
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.